An Interactive Smartphone Application to Motivate Smokers to Quit (StepOne)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Zain Saleem
- Phone Number: 14789 613-696-7000
- Email: zsaleem@ottawaheart.ca
Study Contact Backup
- Name: Ashley Baldwin
- Phone Number: 613-696-7000
- Email: abaldwin@ottawaheart.ca
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Y4W7
- The University of Ottawa Heart Institute
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older.
- Living in Ontario, Canada.
- Current smoker who indicates they are not interested in quitting within the next 30-days.
- Have access to and regularly use a smartphone with internet access.
- Read, write, speaks English or French.
- Available and willing to participate in follow-up assessments over the next 6 months.
- Able to provide consent.
Exclusion Criteria:
- Planning on quitting smoking within the next 30-days.
- Cognitively impaired or experiencing acute psychiatric illness that would alter their ability to participate.
- Institutionalized at a retirement home, nursing home or long-term care facility.
- Has morbid illness which will prevent completion of 6-month follow-up (e.g., receiving palliative care).
- Participating in another smoking cessation program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Usual Care
Eligible smokers randomized to usual care will receive an educational brochure for the University of Ottawa Heart Institute's Ottawa Model for Smoking Cessation (OMSC) Community Program.
The brochure will include information about the OMSC Community Program and how to register for it to receive assistance to quit smoking.
|
|
|
Experimental: Intervention
Eligible smokers randomized to the intervention group will be asked to download the StepOne smartphone application onto their smartphone via the Apple Store or Google Play Store.
They will be provided with a unique ID and unique code, which will enable them to log into the StepOne smartphone application to begin the 14-day program.
Users will interact with the application in the morning and evening; the exact time of the engagement is selected by the participant and ideally at a time that maximizes the likelihood of engaging with the activity.
The application incorporates interactive educational material, daily reminders, gamification, and models of habit formation to engage users.
As with any other smartphone application, users can turn off notifications if they choose to do so.
New content and activities will be shared daily.
|
This smartphone application provides a 14-day program that delivers the core components of smoking cessation (i.e., counseling, education) and takes advantage of pandemic-accelerated acceptance of virtual care, videoconferencing, remote monitoring, and social networking.
The program seeks to move participants from the pre-action stage (not interested in quitting) to the action stage (intention to quit) and incorporates daily reminders, gamification, and models of habit formation to engage users.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported readiness to quit
Time Frame: Day 14
|
Collected via survey
|
Day 14
|
|
Self-reported readiness to quit
Time Frame: Day 45
|
Collected via survey
|
Day 45
|
|
Self-reported readiness to quit
Time Frame: Day 195
|
Collected via survey
|
Day 195
|
|
Having made a quit attempt
Time Frame: Day 14
|
Collected via survey
|
Day 14
|
|
Having made a quit attempt
Time Frame: Day 45
|
Collected via survey
|
Day 45
|
|
Having made a quit attempt
Time Frame: Day 195
|
Collected via survey
|
Day 195
|
|
Rate of smoking cessation
Time Frame: Day 45 for participants who report smoking cessation
|
Biochemically verified using an expired carbon monoxide (CO) test
|
Day 45 for participants who report smoking cessation
|
|
Rate of smoking cessation
Time Frame: Day 195 for participants who report smoking cessation
|
Biochemically verified using an expired carbon monoxide (CO) test
|
Day 195 for participants who report smoking cessation
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Point prevalence abstinence
Time Frame: Day 14, 45, 195
|
Collected via survey
|
Day 14, 45, 195
|
|
Use of behavioural supports (e.g. counselling, quit lines)
Time Frame: Day 14, 45, 195
|
Collected via survey
|
Day 14, 45, 195
|
|
Use of cessation medication and/or e-cigarettes
Time Frame: Day 14, 45, 195
|
Collected via survey
|
Day 14, 45, 195
|
|
Satisfaction and perceived program barriers and facilitators will be assessed for patients in the intervention group
Time Frame: Day 14, 45, 195
|
Collected via survey
|
Day 14, 45, 195
|
|
Number of participants that made a quit attempt
Time Frame: Day 14, 45, 195
|
Collected via survey
|
Day 14, 45, 195
|
|
Change in smoking
Time Frame: Day 14, 45, 195
|
Collected via survey
|
Day 14, 45, 195
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Hassan Mir, MD, The University of Ottawa Heart Institute
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 20220696-01H
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.